3 unknown. 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow ShiYue Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD BGF Inhalation Aerosphere, GFF Inhalation Aerosphere - Pulmonary Disease, Chronic Obstructive | Not applicable | Unknown | ShiYue Li | 50 | 2020-12-30 | 2020-12-19 |
| The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in The Pulmonary Periphral Nodule Transbronchial cryobiopsy/Transbronchial lung biopsy (forcep) - Diagnosis, Complication Rate | Not applicable | Unknown | ShiYue Li | 300 | 2020-12-15 | 2021-10-15 |
| Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer Camrelizumab and Apatinib - Lung Cancer | Phase 1 / Phase 2 | Unknown | ShiYue Li | 20 | 2019-12-01 | 2019-12-17 |
Disease (1) · Lung Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
Cryosurgery (1) · Surgical Instruments (1) · apatinib (1) · camrelizumab (1)
China (2)